query: كان فمة كوكتيل واحد من الأنتيبيوتيك، وهو ZMapp، مشى بالقدا على الأول في هذا المجال، ولكن الدراسات الرسمية ورات أنو الفائدة متاع ها الكوكتال أقل من الفائدة اللي كانوا يلوجوا عليها باش تمنّع من الموت.
positive: One antibody cocktail, ZMapp, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death.
negative: Eight antibody cocktail, ZMapp, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. Five antibody cocktail, ZMapp, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. Four antibody cocktail, ZMapp, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. Nine antibody cocktail, ZMapp, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, AFOSI, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, ATYP, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, AudioBoom, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Bappaka, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Bartibogue, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Commonwealth Federation, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Coney Island, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Cotham School, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Cummings, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, DBO, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Fortitude Valley, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Free Thai, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Funagira Dam, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, General Liu, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Groult, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Hammer, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Independent Commission Against Corruption, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Italy U17, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Kawhatau River, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Khmer, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Little Kittens, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, MDOT, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, National Vegetation Classification, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, New Dimensions, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Newburgh Free Academy, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, OFUNAM, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Odelein, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Original Sin, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Philemon, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Poltergeist, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Professor Keval Ronald Adam, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Rosy Apples, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, SV, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Swan Silvertones, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Taneční, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Tonfannau, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, UNESCO Artistic Freedom Leaflet, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Universidad Alas Peruanas, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, VI Lenin Bakhchysarai, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Volksraad, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Wasantha Moragoda, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Yamazaki, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, Youth Aliyah, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. One antibody cocktail, ZMapp, initially showed promise in the field, but informal studies indicated it had more benefit than sought in preventing death. Seven antibody cocktail, ZMapp, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. Six antibody cocktail, ZMapp, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. Three antibody cocktail, ZMapp, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death.